1. LOW RATE OF TOXICITY IN OLDER CANCER PATIENTS TREATED WITH IMMUNOTHERAPY. (November 2019) Authors: Van Der Ziel, D.; De Glas, N.; Storm, B.; Bastiaannet, E.; Visser, L.; Wilms, E.; Codrington, H.; Houtsma, D.; Portielje, J.; Van Den Bos, F. Journal: Journal of geriatric oncology Issue: Volume 10(2019)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: an observational study. (December 2021) Authors: Storm, B.; Abedian Kalkhoran, H.; Wilms, E.; Brocken, P.; Codrington, H.; Houtsma, D.; Portielje, J.; de Glas, N.; van der Ziel, D.; van den Bos, F.; Visser, L. Journal: Journal of geriatric oncology Issue: Volume 12(2021)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗